Literature DB >> 8289197

Adenosine deaminase inhibitors: synthesis and structure-activity relationships of 2-hydroxy-3-nonyl derivatives of azoles.

G Cristalli1, A Eleuteri, R Volpini, S Vittori, E Camaioni, G Lupidi.   

Abstract

A series of erythro-1-(2-hydroxy-3-nonyl)azole derivatives have been synthesized and evaluated for adenosine deaminase (ADA) inhibitory activity, in order to introduce simplifications in the ADA inhibitor erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, 1a). The synthesis of most of the reported compounds was achieved by reaction of 2-bromo-3-nonanone with the suitable azole followed by reduction of the carbonyl group to give a diastereoisomeric mixture of N-substituted (2-hydroxy-3-nonyl)azoles. Separation of diastereoisomers was achieved by HPLC or by preparative TLC plates. The results of the enzymatic test indicate that the nitrogen in the 3-position, and secondly, the nitrogen in the 5-position are very important for the interaction of the azole ring with the inhibitory site on the enzyme. In fact, the pyrazole and the 2-substituted 1,2,3-triazole derivatives (10 and 15, respectively) are nearly inactive, whereas the erythro-1-(2- hydroxy-3-nonyl)-1,2,4-triazole (18e) was the most potent ADA inhibitor in the series with Ki = 0.3 microM.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8289197     DOI: 10.1021/jm00027a026

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

Review 1.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

2.  Predicting target-ligand interactions with graph convolutional networks for interpretable pharmaceutical discovery.

Authors:  Paola Ruiz Puentes; Laura Rueda-Gensini; Natalia Valderrama; Isabela Hernández; Cristina González; Laura Daza; Carolina Muñoz-Camargo; Juan C Cruz; Pablo Arbeláez
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

3.  Identification of a New Uncompetitive Inhibitor of Adenosine Deaminase from Endophyte Aspergillus niger sp.

Authors:  Xin-Guo Zhang; Jin-Wen Liu; Peng Tang; Zi-Yu Liu; Guang-Jun Guo; Qiao-Yun Sun; Jian-Jun Yin
Journal:  Curr Microbiol       Date:  2017-12-14       Impact factor: 2.188

4.  Role of phosphodiesterase 2 in growth and invasion of human malignant melanoma cells.

Authors:  Kenichi Hiramoto; Taku Murata; Kasumi Shimizu; Hiroshi Morita; Madoka Inui; Vincent C Manganiello; Toshiro Tagawa; Naoya Arai
Journal:  Cell Signal       Date:  2014-04-03       Impact factor: 4.315

Review 5.  Therapeutic Perspectives of Adenosine Deaminase Inhibition in Cardiovascular Diseases.

Authors:  Barbara Kutryb-Zajac; Paulina Mierzejewska; Ewa M Slominska; Ryszard T Smolenski
Journal:  Molecules       Date:  2020-10-12       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.